{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:23:12Z","timestamp":1792498992547,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1038\/s41433-025-03790-6","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T15:17:06Z","timestamp":1744211826000},"page":"1457-1464","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Is Botulinum toxin A effective in treating dry eye disease? A systematic review and meta-analysis"],"prefix":"10.1038","volume":"39","author":[{"given":"Kai-Yang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoi-Chun","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6981-3411","authenticated-orcid":false,"given":"Chi-Ming","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"3790_CR1","first-page":"107","volume":"77","author":"M Zemanov\u00e1","year":"2021","unstructured":"Zemanov\u00e1 M. Dry eye disease. A review. Cesk Slov Oftalmol. 2021;77:107\u201319.","journal-title":"Cesk Slov Oftalmol"},{"key":"3790_CR2","doi-asserted-by":"crossref","unstructured":"The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007; 5:75\u201392.","DOI":"10.1016\/S1542-0124(12)70081-2"},{"key":"3790_CR3","doi-asserted-by":"publisher","unstructured":"Chen KY, Lee HK, Chan HC, Chan CM. Is multiwavelength photobiomodulation effective and safe for age-related macular degeneration? A systematic review and meta-analysis. Ophthalmol Ther. 2025. https:\/\/doi.org\/10.1007\/s40123-025-01119-w.","DOI":"10.1007\/s40123-025-01119-w"},{"key":"3790_CR4","doi-asserted-by":"crossref","first-page":"102786","DOI":"10.1016\/j.redox.2023.102786","volume":"64","author":"P Sekar","year":"2023","unstructured":"Sekar P, Hsiao G, Hsu SH, Huang DY, Lin WW, Chan CM. Metformin inhibits methylglyoxal-induced retinal pigment epithelial cell death and retinopathy via AMPK-dependent mechanisms: reversing mitochondrial dysfunction and upregulating glyoxalase 1. Redox Biol. 2023;64:102786.","journal-title":"Redox Biol"},{"key":"3790_CR5","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jtos.2014.02.002","volume":"12","author":"AJ Bron","year":"2014","unstructured":"Bron AJ, Tomlinson A, Foulks GN, Pepose JS, Baudouin C, Geerling G, et al. Rethinking dry eye disease: a perspective on clinical implications. Ocul Surf. 2014;12:S1\u201331.","journal-title":"Ocul Surf"},{"key":"3790_CR6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jtos.2016.03.003","volume":"14","author":"AF Ablamowicz","year":"2016","unstructured":"Ablamowicz AF, Nichols JJ. Ocular surface membrane-associated mucins. Ocul Surf. 2016;14:331\u201341.","journal-title":"Ocul Surf"},{"key":"3790_CR7","doi-asserted-by":"crossref","first-page":"102257","DOI":"10.1016\/j.clae.2024.102257","volume":"47","author":"M Vidal-Rohr","year":"2024","unstructured":"Vidal-Rohr M, Craig JP, Davies LN, Wolffsohn JS. Classification of dry eye disease subtypes. Cont Lens Anterior Eye. 2024;47:102257.","journal-title":"Cont Lens Anterior Eye"},{"key":"3790_CR8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/07853890.2022.2157477","volume":"55","author":"J Sheppard","year":"2023","unstructured":"Sheppard J, Shen Lee B, Periman LM. Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists. Ann Med. 2023;55:241\u201352.","journal-title":"Ann Med"},{"key":"3790_CR9","doi-asserted-by":"crossref","unstructured":"Narang P, Donthineni PR, D\u2019Souza S, Basu S. Evaporative dry eye disease due to meibomian gland dysfunction: Preferred practice pattern guidelines for diagnosis and treatment. Indian J Ophthalmol. 2023;71:1348\u201356.","DOI":"10.4103\/IJO.IJO_2841_22"},{"key":"3790_CR10","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/ICL.0000000000000643","volume":"46","author":"K Tsubota","year":"2020","unstructured":"Tsubota K, Yokoi N, Watanabe H, Dogru M, Kojima T, Yamada M, et al. A new perspective on dry eye classification: proposal by the Asia dry eye society. Eye Contact Lens. 2020;46:S2\u2013s13.","journal-title":"Eye Contact Lens"},{"key":"3790_CR11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.exer.2013.07.027","volume":"117","author":"RR Hodges","year":"2013","unstructured":"Hodges RR, Dartt DA. Tear film mucins: front line defenders of the ocular surface; comparison with airway and gastrointestinal tract mucins. Exp Eye Res. 2013;117:62\u201378.","journal-title":"Exp Eye Res"},{"key":"3790_CR12","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15:276\u201383.","journal-title":"Ocul Surf"},{"key":"3790_CR13","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.37765\/ajmc.2021.88625","volume":"27","author":"JD Dunn","year":"2021","unstructured":"Dunn JD, Karpecki PM, Meske ME, Reissman D. Evolving knowledge of the unmet needs in dry eye disease. Am J Manag Care. 2021;27:S23\u2013S32.","journal-title":"Am J Manag Care"},{"key":"3790_CR14","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1002\/mds.10065","volume":"17","author":"C Evinger","year":"2002","unstructured":"Evinger C, Bao JB, Powers AS, Kassem IS, Schicatano EJ, Henriquez VM, et al. Dry eye, blinking, and blepharospasm. Mov Disord. 2002;17:S75\u201378.","journal-title":"Mov Disord"},{"key":"3790_CR15","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.4103\/IJO.IJO_599_23","volume":"71","author":"R Shetty","year":"2023","unstructured":"Shetty R, Sethu S. Newer paradigms in dry eye disease research. Indian J Ophthalmol. 2023;71:1064.","journal-title":"Indian J Ophthalmol"},{"key":"3790_CR16","doi-asserted-by":"crossref","first-page":"996","DOI":"10.4103\/ajns.AJNS_48_19","volume":"14","author":"JS Gosal","year":"2019","unstructured":"Gosal JS, Das KK, Khatri D, Attri G, Jaiswal AK. \u201cContralateral Dry Eye in Hemifacial Spasm:\u201d A New Clinical Sign. Asian J Neurosurg. 2019;14:996\u20138.","journal-title":"Asian J Neurosurg"},{"key":"3790_CR17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/ICO.0000000000000712","volume":"35","author":"K Asiedu","year":"2016","unstructured":"Asiedu K, Kyei S, Mensah SN, Ocansey S, Abu LS, Kyere EA. Ocular surface disease index (OSDI) versus the standard patient evaluation of eye dryness (SPEED): a study of a nonclinical sample. Cornea. 2016;35:175\u201380.","journal-title":"Cornea"},{"key":"3790_CR18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jtos.2018.08.004","volume":"17","author":"Y Tagawa","year":"2019","unstructured":"Tagawa Y, Noda K, Ohguchi T, Ishida S, Kitaichi N. Corneal hyperalgesia in patients with short tear film break-up time dry eye. Ocul Surf. 2019;17:55\u201359.","journal-title":"Ocul Surf"},{"key":"3790_CR19","unstructured":"Brott NR, Zeppieri M, Ronquillo Y. Schirmer Test. [Updated 2024 Feb 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559159\/."},{"key":"3790_CR20","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2147\/OPTH.S105275","volume":"10","author":"H Miyake","year":"2016","unstructured":"Miyake H, Kawano Y, Tanaka H, Iwata A, Imanaka T, Nakamura M. Tear volume estimation using a modified Schirmer test: a randomized, multicenter, double-blind trial comparing 3% diquafosol ophthalmic solution and artificial tears in dry eye patients. Clin Ophthalmol. 2016;10:879\u201386.","journal-title":"Clin Ophthalmol"},{"key":"3790_CR21","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/ICO.0000000000000575","volume":"34","author":"J Baek","year":"2015","unstructured":"Baek J, Doh SH, Chung SK. Comparison of tear meniscus height measurements obtained with the keratograph and Fourier domain optical coherence tomography in dry eye. Cornea. 2015;34:1209\u201313.","journal-title":"Cornea"},{"key":"3790_CR22","doi-asserted-by":"crossref","unstructured":"Pena-Verdeal H, Garcia-Queiruga J, Sabucedo-Villamarin B, Garcia-Resua C, Giraldez MJ, Yebra-Pimentel E. A comprehensive study on tear meniscus height inter-eye differences in aqueous deficient dry eye diagnosis. J Clin Med. 2024;13.","DOI":"10.3390\/jcm13030659"},{"key":"3790_CR23","doi-asserted-by":"crossref","first-page":"518e","DOI":"10.1097\/01.prs.0000475758.63709.23","volume":"137","author":"H Sundaram","year":"2016","unstructured":"Sundaram H, Signorini M, Liew S, Trindade de Almeida AR, Wu Y, Vieira Braz A, et al. Global aesthetics consensus: Botulinum toxin type A\u2014evidence-based review, emerging concepts, and consensus recommendations for aesthetic use, including updates on complications. Plast Reconstr Surg. 2016;137:518e\u2013529e.","journal-title":"Plast Reconstr Surg"},{"key":"3790_CR24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000131089","volume":"41","author":"S Sahlin","year":"2008","unstructured":"Sahlin S, Linderoth R. Eyelid botulinum toxin injections for the dry eye. Dev Ophthalmol. 2008;41:187\u201392.","journal-title":"Dev Ophthalmol"},{"key":"3790_CR25","doi-asserted-by":"crossref","unstructured":"Lee AG, Lee SH, Jang M, Lee SJ, Shin HJ-. Transconjunctival versus transcutaneous injection of Botulinum toxin into the lacrimal gland to reduce lacrimal production: a randomized controlled trial. Toxins (Basel) 2021;13.","DOI":"10.3390\/toxins13020077"},{"key":"3790_CR26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10792-024-03300-9","volume":"44","author":"KY Chen","year":"2024","unstructured":"Chen KY, Chan HC, Wei LY, Chan CM. Efficacy of gabapentin and pregabalin for treatment of post refractive surgery pain: a systematic review and meta-analysis. Int Ophthalmol. 2024;44:409.","journal-title":"Int Ophthalmol"},{"key":"3790_CR27","doi-asserted-by":"crossref","unstructured":"Ho RW, Fang PC, Chang CH, Liu YP, Kuo MT. A review of periocular Botulinum neurotoxin on the tear film homeostasis and the ocular surface change. Toxins (Basel) 2019;11:66.","DOI":"10.3390\/toxins11020066"},{"key":"3790_CR28","volume":"10","author":"KY Chen","year":"2024","unstructured":"Chen KY, Chan HC, Chan CM. Is retinal vein occlusion highly associated with an increased risk of myocardial infarction? A systematic review and meta-analysis. Int J Retin Vitreous. 2024;10. 86.","journal-title":"Int J Retin Vitreous"},{"key":"3790_CR29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/OPTH.S498869","volume":"19","author":"KY Chen","year":"2025","unstructured":"Chen KY, Chan HC, Chan CM. Is thermal pulsation therapy effective for dry eyes before and after cataract surgery? A systematic review and meta-analysis. Clin Ophthalmol. 2025;19:19\u201333.","journal-title":"Clin Ophthalmol"},{"key":"3790_CR30","unstructured":"NIH N. Study Quality Assessment Tools. NIH. Available at: https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools. Accessed October 25, 2024, 2024."},{"key":"3790_CR31","first-page":"14898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. Br Med J. 2019;366:14898.","journal-title":"Br Med J"},{"key":"3790_CR32","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. Br Med J. 2016;355:i4919.","journal-title":"Br Med J"},{"key":"3790_CR33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","volume":"12","author":"LA McGuinness","year":"2021","unstructured":"McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021;12:55\u201361.","journal-title":"Res Synth Methods"},{"key":"3790_CR34","unstructured":"R Studio [computer program]. Version 2024.09.0 Build 375; 2024."},{"key":"3790_CR35","first-page":"e132","volume":"95","author":"JC Serna-Ojeda","year":"2017","unstructured":"Serna-Ojeda JC, Nava-Castaneda A. Paralysis of the orbicularis muscle of the eye using botulinum toxin type A in the treatment for dry eye. Acta Ophthalmol. 2017;95:e132\u2013e137.","journal-title":"Acta Ophthalmol"},{"key":"3790_CR36","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00417-018-4194-3","volume":"257","author":"MG Choi","year":"2019","unstructured":"Choi MG, Yeo JH, Kang JW, Chun YS, Lee JK, Kim JC. Effects of botulinum toxin type A on the treatment of dry eye disease and tear cytokines. Graefes Arch Clin Exp Ophthalmol. 2019;257:331\u20138.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3790_CR37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40123-017-0079-5","volume":"6","author":"SM Fouda","year":"2017","unstructured":"Fouda SM, Mattout HK. Comparison between Botulinum toxin A injection and lacrimal punctal plugs for the control of post-LASIK dry eye manifestations: a prospective study. Ophthalmol Ther. 2017;6:167\u201374.","journal-title":"Ophthalmol Ther"},{"key":"3790_CR38","doi-asserted-by":"crossref","unstructured":"Choi EW, Yeom DJ, Jang SY. Botulinum Toxin A injection for the treatment of intractable dry eye disease. Medicina (Kaunas). 2021;57:247.","DOI":"10.3390\/medicina57030247"},{"key":"3790_CR39","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/jamaophthalmol.2013.6243","volume":"132","author":"MC Ho","year":"2014","unstructured":"Ho MC, Hsu WC, Hsieh YT. Botulinum toxin type a injection for lateral canthal rhytids: effect on tear film stability and tear production. JAMA Ophthalmol. 2014;132:332\u20137.","journal-title":"JAMA Ophthalmol"},{"key":"3790_CR40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jtos.2024.11.009","volume":"35","author":"A Sawaed","year":"2024","unstructured":"Sawaed A, Friedrich SN, Farhan A, Nassar A, Hamed M, Hartstein M, et al. The effect of botulinum neurotoxin A injections on meibomian glands and dry eye. Ocul Surf. 2024;35:25\u201330.","journal-title":"Ocul Surf"},{"key":"3790_CR41","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1007\/s00417-023-06141-x","volume":"261","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Wang W, Lin Z, Lin T, Gong L. Relations between nonmotor manifestations and motor disorders in patients with benign essential blepharospasm. Graefes Arch Clin Exp Ophthalmol. 2023;261:3615\u201323.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3790_CR42","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s10384-016-0469-6","volume":"60","author":"Y Isshiki","year":"2016","unstructured":"Isshiki Y, Ishikawa H, Mimura O. Changes in ocular higher-order aberrations following botulinum toxin treatment in patients with blepharospasm: BTX improves dry eye in patients with BEB. Jpn J Ophthalmol. 2016;60:486\u201391.","journal-title":"Jpn J Ophthalmol"},{"key":"3790_CR43","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/IOP.0000000000002375","volume":"39","author":"C Yabumoto","year":"2023","unstructured":"Yabumoto C, Osaki MH, Osaki T, Gameiro GR, Campos M, Osaki TH. Ocular surface metrics in blepharospasm patients after treatment with botulinum toxin injections. Ophthalmic Plast Reconstr Surg. 2023;39:475\u20138.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"3790_CR44","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.2147\/OPTH.S305817","volume":"15","author":"S Jariyakosol","year":"2021","unstructured":"Jariyakosol S, Uthaithammarat L, Chatwichaikul N, Kasetsuwan N, Chongpison Y. Dry eye disease in hemifacial spasm patients treated with Botulinum toxin type A. Clin Ophthalmol. 2021;15:1775\u201382.","journal-title":"Clin Ophthalmol"},{"key":"3790_CR45","first-page":"e108","volume":"91","author":"DI Park","year":"2013","unstructured":"Park DI, Shin HM, Lee SY, Lew H. Tear production and drainage after botulinum toxin A injection in patients with essential blepharospasm. Acta Ophthalmol. 2013;91:e108\u2013112.","journal-title":"Acta Ophthalmol"},{"key":"3790_CR46","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1007\/s10792-022-02253-1","volume":"42","author":"N Bayraktar Bilen","year":"2022","unstructured":"Bayraktar Bilen N, Bilen \u015e, Top\u00e7u Y\u0131lmaz P, Evren Kemer \u00d6. Tear meniscus, corneal topographic and aberrometric changes after botulinum toxin-a injection in patients with blepharospasm and hemifacial spasm. Int Ophthalmol. 2022;42:2625\u201332.","journal-title":"Int Ophthalmol"},{"key":"3790_CR47","volume":"15","author":"KY Chen","year":"2025","unstructured":"Chen KY, Chan HC, Chan CM. Do people with diabetes have a higher risk of developing postoperative endophthalmitis after cataract surgery? A systematic review and meta-analysis. J Ophthalmic Inflamm Infect. 2025;15:24.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"3790_CR48","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1097\/ICO.0000000000000482","volume":"34","author":"A Gunes","year":"2015","unstructured":"Gunes A, Demirci S, Koyuncuoglu HR, Tok L, Tok O. Corneal and tear film changes after Botulinum toxin-a in blepharospasm or hemifacial spasm. Cornea. 2015;34:906\u201310.","journal-title":"Cornea"},{"key":"3790_CR49","first-page":"5173","volume":"58","author":"Y Joonhyung","year":"2017","unstructured":"Joonhyung Y, Kim JC. Effects of botulinum toxin type A for the treatment of dry eye syndrome and tear biomarkers. Invest Ophthalmol Vis Sci. 2017;58:5173.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3790_CR50","volume":"19","author":"N Venkateswaran","year":"2020","unstructured":"Venkateswaran N, Hwang J, Rong AJ, Levitt AE, Diel RJ, Levitt RC, et al. Periorbital botulinum toxin A improves photophobia and sensations of dryness in patients without migraine: case series of four patients. Am J Ophthalmol Case Rep. 2020;19:100809.","journal-title":"Am J Ophthalmol Case Rep"},{"key":"3790_CR51","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.jfo.2021.05.009","volume":"44","author":"B Girard","year":"2021","unstructured":"Girard B, de Saint Sauveur G. Tear osmolarity, dry eye syndrome, blepharospasm and botulinum neurotoxin. J Fr Ophtalmol. 2021;44:1553\u20139.","journal-title":"J Fr Ophtalmol"},{"key":"3790_CR52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/0974-620X.137142","volume":"7","author":"AA Bukhari","year":"2014","unstructured":"Bukhari AA. Botulinum neurotoxin type A versus punctal plug insertion in the management of dry eye disease. Oman J Ophthalmol. 2014;7:61\u201365.","journal-title":"Oman J Ophthalmol"},{"key":"3790_CR53","volume":"25","author":"KY Chen","year":"2025","unstructured":"Chen KY, Chan HC, Chan CM. Is there an association between retinal vein occlusion and cerebrovascular accident? A systematic review and meta-analysis. BMC Ophthalmol. 2025;25:112.","journal-title":"BMC Ophthalmol"},{"key":"3790_CR54","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/cosmetics8020029","volume":"8","author":"T Abe","year":"2021","unstructured":"Abe T, Loenneke JP. Orbicularis oculi muscle size and function: exploring the influence of aging and exercise training. Cosmetics. 2021;8:29.","journal-title":"Cosmetics"},{"key":"3790_CR55","doi-asserted-by":"crossref","unstructured":"Kim YS, Hong ES, Kim HS. Botulinum toxin in the field of dermatology: novel indications. Toxins (Basel). 2017;9:403.","DOI":"10.3390\/toxins9120403"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03790-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03790-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03790-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T12:26:15Z","timestamp":1747657575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03790-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["3790"],"URL":"https:\/\/doi.org\/10.1038\/s41433-025-03790-6","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"18 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable. This study does not involve individual data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable. This study does not involve human participants, human data or human tissue.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}